×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RANI – rani therapeutics holdings, inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RANI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/27
08:02 am
rani
Rani Therapeutics (RANI) had its "buy" rating reaffirmed by HC Wainwright. They now have a $11.00 price target on the stock.
High
Report
Rani Therapeutics (RANI) had its "buy" rating reaffirmed by HC Wainwright. They now have a $11.00 price target on the stock.
3/26
08:17 pm
rani
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/26
05:56 pm
rani
Rani Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Rani Therapeutics Q4 Earnings Call Highlights [Yahoo! Finance]
3/26
04:39 pm
rani
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update [Yahoo! Finance]
High
Report
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update [Yahoo! Finance]
3/26
04:05 pm
rani
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
High
Report
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
3/25
04:53 pm
rani
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Medium
Report
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
3/19
04:55 pm
rani
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/19
04:05 pm
rani
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
Date
Time
Symbol
Company Name
Action
%Chg
3/26/2026
04:05 pm
rani
rani therapeutics holdings, inc. - class a
MISS
Report
-24.9%
rani therapeutics holdings, inc. - class a
8/7/2025
04:05 pm
rani
rani therapeutics holdings, inc. - class a
BEAT
Report
-3.0%
rani therapeutics holdings, inc. - class a
5/13/2025
04:05 pm
rani
rani therapeutics holdings, inc. - class a
IN-LINE
Report
17.0%
rani therapeutics holdings, inc. - class a
3/31/2025
04:05 pm
rani
rani therapeutics holdings, inc. - class a
MISS
Report
-6.8%
rani therapeutics holdings, inc. - class a
Date
Time
Symbol
Headline
Impact
3/27
07:47 pm
rani
Form 3 Rani Therapeutics Holdin For: Mar 18 Filed by: Javadi Alireza
Low
Report
Form 3 Rani Therapeutics Holdin For: Mar 18 Filed by: Javadi Alireza
3/27
11:33 am
rani
Form SCHEDULE 13G/A Rani Therapeutics Holdin Filed by: VANGUARD GROUP INC
Medium
Report
Form SCHEDULE 13G/A Rani Therapeutics Holdin Filed by: VANGUARD GROUP INC
3/26
04:47 pm
rani
Form S-8 Rani Therapeutics Holdin
High
Report
Form S-8 Rani Therapeutics Holdin
3/26
04:44 pm
rani
Form 10-K Rani Therapeutics Holdin For: Dec 31
High
Report
Form 10-K Rani Therapeutics Holdin For: Dec 31
3/26
04:10 pm
rani
Form 8-K Rani Therapeutics Holdin For: Mar 26
High
Report
Form 8-K Rani Therapeutics Holdin For: Mar 26
2/13
12:31 pm
rani
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: AWM Investment Company, Inc.
Medium
Report
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: AWM Investment Company, Inc.
2/12
01:45 pm
rani
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: SymBiosis Capital Partners, LLC
Low
Report
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: SymBiosis Capital Partners, LLC
1/30
02:44 pm
rani
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G Rani Therapeutics Holdin Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: